Leeza Osipenko PhD, MSc

Leeza joined NICE in 2012 and has been leading the Scientific Advice (SA) service since 2014. She works closely with EMA, MHRA, and European HTA agencies. Leeza chairs most of the national, international and parallel scientific advice meetings for medical device and pharmaceutical product developers. She also signs off key deliverables produced by NICE SA and is responsible for the team’s operations and performance. Leeza’s research interests focus on methodologies of trial design, evidence generation for economic modelling and policy implications of HTA.